Author: Sanjiv Shah, Head, Global Life Sciences Practice, Intelligroup

This past week a giant drug maker expanded the recall of their blockbuster cholesterol reduction medication bottles due to a musty odor in the bottles, bringing the total number of recalled bottles to more than 360,000. In the same week, another giant drug maker agreed to pay a $750 million fine for quality related violations at one of their plants that resulted in contaminated and mislabeled product entering the supply chain.
(more…)